
Pacific Biosciences of California PACB
$ 1.72
-2.68%
Quarterly report 2025-Q3
added 11-06-2025
Pacific Biosciences of California Historical Prices 2011-2025 | PACB
Annual Historical Prices Pacific Biosciences of California
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5.57 | 9.11 | 20.5 | 25.9 | 5.14 | 7.4 | 2.64 | 3.8 | 13.1 | 7.84 | 5.23 | 1.7 | 2.8 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 25.9 | 1.7 | 8.52 |
Historical Prices of other stocks in the Diagnostics research industry
| Issuer | Historical Prices | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
0.38 | - | -6.23 % | $ 30.6 M | ||
|
Akumin
AKU
|
0.84 | - | -17.87 % | $ 25.9 M | ||
|
Accelerate Diagnostics
AXDX
|
0.49 | - | -61.36 % | $ 2.46 M | ||
|
Brainsway Ltd.
BWAY
|
8.85 | $ 18.68 | -3.56 % | $ 99.4 M | ||
|
Burning Rock Biotech Limited
BNR
|
8.43 | $ 20.26 | -6.03 % | $ 218 M | ||
|
Co-Diagnostics
CODX
|
1.19 | $ 0.23 | -3.83 % | $ 6.75 M | ||
|
Biocept
BIOC
|
0.35 | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
0.39 | - | 0.22 % | $ 16.8 M | ||
|
Castle Biosciences
CSTL
|
25.5 | $ 39.13 | -0.67 % | $ 1.09 B | ||
|
Danaher Corporation
DHR
|
208 | $ 230.63 | 0.13 % | $ 169 B | ||
|
BioNano Genomics
BNGO
|
2.79 | $ 1.51 | -0.66 % | $ 1.92 M | ||
|
DarioHealth Corp.
DRIO
|
1.53 | $ 10.22 | 1.79 % | $ 290 M | ||
|
Exact Sciences Corporation
EXAS
|
50.3 | $ 101.55 | -0.02 % | $ 18.8 B | ||
|
DexCom
DXCM
|
126 | $ 68.07 | 0.74 % | $ 26.3 B | ||
|
Enzo Biochem
ENZ
|
1.13 | - | -8.98 % | $ 14.8 K | ||
|
Fulgent Genetics
FLGT
|
15.4 | $ 26.58 | -0.52 % | $ 804 M | ||
|
Global Cord Blood Corporation
CO
|
2.5 | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
1.44 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
0.87 | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
1.3 | - | -11.32 % | $ 2.94 M | ||
|
CareDx, Inc
CDNA
|
9.69 | $ 19.2 | -1.41 % | $ 1.03 B | ||
|
Celcuity
CELC
|
10.1 | $ 100.79 | -1.43 % | $ 3.98 B | ||
|
Heska Corporation
HSKA
|
81.6 | - | - | $ 1.31 B | ||
|
Anixa Biosciences
ANIX
|
2.22 | $ 3.15 | -1.56 % | $ 100 K | ||
|
HTG Molecular Diagnostics
HTGM
|
3.36 | - | -20.0 % | $ 1.06 M | ||
|
IQVIA Holdings
IQV
|
197 | $ 226.62 | -0.13 % | $ 41.1 B | ||
|
Guardant Health
GH
|
47.6 | $ 102.07 | -0.88 % | $ 12.5 B | ||
|
Aspira Women's Health
AWH
|
0.39 | - | -6.19 % | $ 10.5 M | ||
|
Myriad Genetics
MYGN
|
10.7 | $ 6.4 | -1.23 % | $ 580 M | ||
|
ENDRA Life Sciences
NDRA
|
4.1 | $ 4.92 | -1.4 % | $ 2.64 M | ||
|
Neogen Corporation
NEOG
|
4.7 | $ 7.27 | 1.94 % | $ 1.58 B | ||
|
Illumina
ILMN
|
103 | $ 134.24 | -0.53 % | $ 21.3 B | ||
|
Charles River Laboratories International
CRL
|
166 | $ 202.71 | -0.41 % | $ 10.4 B | ||
|
National Research Corporation
NRC
|
41.1 | $ 18.43 | -1.23 % | $ 452 M | ||
|
Quest Diagnostics Incorporated
DGX
|
172 | $ 175.51 | -0.26 % | $ 19.5 B | ||
|
Biodesix
BDSX
|
0.71 | $ 6.65 | -2.57 % | $ 862 M | ||
|
Motus GI Holdings
MOTS
|
0.64 | - | -34.28 % | $ 263 K | ||
|
Laboratory Corporation of America Holdings
LH
|
252 | $ 253.42 | -0.21 % | $ 21.3 B | ||
|
ICON Public Limited Company
ICLR
|
201 | $ 182.22 | -0.34 % | $ 15 B | ||
|
IDEXX Laboratories
IDXX
|
457 | $ 685.3 | -0.46 % | $ 56.5 B | ||
|
Lantheus Holdings
LNTH
|
93.4 | $ 67.03 | 0.48 % | $ 4.64 B | ||
|
Mettler-Toledo International
MTD
|
1.41 K | $ 1 413.45 | -0.48 % | $ 30 B | ||
|
Agilent Technologies
A
|
139 | $ 138.24 | -0.11 % | $ 42 B | ||
|
Koninklijke Philips N.V.
PHG
|
25.5 | $ 27.33 | 0.83 % | $ 20 B | ||
|
Biomerica
BMRA
|
3.13 | $ 2.7 | - | $ 6.2 M | ||
|
Bioventus
BVS
|
5.6 | $ 7.47 | 0.13 % | $ 468 M | ||
|
Personalis
PSNL
|
4.28 | $ 8.13 | -0.12 % | $ 482 M |